ONTOLOGY REPORT - ANNOTATIONS
| Term: | Liver Cirrhosis, Experimental |
|
| Accession: | RDO:0006022
|
browse the term
|
| Definition: | Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS. |
| Synonyms: | exact_synonym: | Experimental Hepatic Cirrhosis; Experimental Liver Cirrhoses |
| | primary_id: | MESH:D008106 |
|
|
Liver Cirrhosis, Experimental
|
| G |
Adm |
adrenomedullin |
|
|
IEP |
1 |
168,380,255 |
168,382,426 |
RGD:1625319 |
RGD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
|
IEP |
1 |
263,025,655 |
263,027,055 |
RGD:5129118 |
RGD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
|
IEP |
18 |
58,174,958 |
58,177,000 |
RGD:5129118 |
RGD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
|
IEP |
16 |
69,163,620 |
69,166,384 |
RGD:5129118 |
RGD |
| G |
Adrbk1 |
adrenergic, beta, receptor kinase 1 |
|
|
IEP |
1 |
206,873,002 |
206,892,868 |
RGD:1625784 |
RGD |
| G |
Angpt1 |
angiopoietin 1 |
|
Disease_progression |
IEP |
7 |
78,195,504 |
78,451,471 |
RGD:1643338 |
RGD |
| G |
Angpt2 |
angiopoietin 2 |
|
|
IEP |
16 |
75,891,757 |
75,942,255 |
RGD:2314174 |
RGD |
| G |
Anxa1 |
annexin A1 |
|
|
IEP |
1 |
223,478,436 |
223,494,455 |
RGD:2306954 |
RGD |
| G |
Apoa1 |
apolipoprotein A-I |
|
|
IED |
|
|
|
RGD:1599161 |
RGD |
| G |
Arg1 |
arginase, liver |
|
|
IEP |
1 |
20,998,894 |
21,011,275 |
RGD:1626298 |
RGD |
| G |
Arg2 |
arginase type II |
|
|
IEP |
6 |
101,901,653 |
101,928,282 |
RGD:1626298 |
RGD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
|
IEP |
3 |
10,578,717 |
10,622,332 |
RGD:4140452 |
RGD |
| G |
B2m |
beta-2 microglobulin |
|
|
IEP |
3 |
108,927,919 |
108,932,718 |
RGD:6482712 |
RGD |
| G |
Bak1 |
BCL2-antagonist/killer 1 |
|
|
IEP |
20 |
5,255,954 |
5,264,593 |
RGD:2315709 |
RGD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
|
IEP |
|
|
|
RGD:2293129 |
RGD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
|
IEP |
15 |
22,283,171 |
22,286,757 |
RGD:1643229 |
RGD |
| G |
Casp12 |
caspase 12 |
|
|
IEP |
8 |
2,082,933 |
2,110,511 |
RGD:2311470 |
RGD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
|
IEP |
10 |
70,256,263 |
70,258,061 |
RGD:2307001 |
RGD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
|
IEP |
10 |
70,267,281 |
70,269,131 |
RGD:6483766 |
RGD |
| G |
Cd38 |
CD38 molecule |
|
|
IEP |
14 |
72,320,479 |
72,360,329 |
RGD:2307239 |
RGD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
|
IEP |
7 |
2,000,196 |
2,007,682 |
RGD:2289284 |
RGD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
|
IEP |
|
|
|
RGD:2289284 |
RGD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
|
IPM |
10 |
83,622,438 |
83,639,368 |
RGD:5688339 |
RGD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
|
IEP |
10 |
83,622,438 |
83,639,368 |
RGD:1601595 |
RGD |
| G |
Col6a2 |
collagen, type VI, alpha 2 |
|
|
IEP |
20 |
12,436,783 |
12,464,512 |
RGD:1600938 |
RGD |
| G |
Cps1 |
carbamoyl-phosphate synthetase 1 |
|
|
IEP |
9 |
65,907,211 |
66,017,942 |
RGD:2303515 |
RGD |
| G |
Ctgf |
connective tissue growth factor |
|
|
IEP |
1 |
21,327,099 |
21,330,215 |
RGD:2314367 |
RGD |
| G |
Dag1 |
dystroglycan 1 (dystrophin-associated glycoprotein 1) |
|
|
IEP |
8 |
113,470,871 |
113,483,433 |
RGD:2314895 |
RGD |
| G |
Dbh |
dopamine beta-hydroxylase (dopamine beta-monooxygenase) |
|
|
IEP |
3 |
6,052,706 |
6,069,826 |
RGD:5129683 |
RGD |
| G |
Ddc |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
|
IEP |
14 |
92,698,636 |
92,788,635 |
RGD:5129683 |
RGD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
|
IEP |
1 |
238,259,443 |
238,274,745 |
RGD:2290284 |
RGD |
| G |
Fgg |
fibrinogen gamma chain |
|
|
IEP |
2 |
174,727,312 |
174,734,594 |
RGD:1599810 |
RGD |
| G |
Ghr |
growth hormone receptor |
|
|
IEP |
2 |
52,496,517 |
52,658,066 |
RGD:2307378 |
RGD |
| G |
Gsn |
gelsolin |
|
|
IEP |
3 |
14,360,245 |
14,386,313 |
RGD:1599866 |
RGD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
|
IED |
19 |
13,963,139 |
13,969,960 |
RGD:4145305 |
RGD |
| G |
Hp |
haptoglobin |
|
|
IEP |
19 |
39,443,016 |
39,447,566 |
RGD:1626367 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
ISS |
7 |
24,531,669 |
24,605,742 |
RGD:2317647 |
RGD |
| G |
Itgb6 |
integrin, beta 6 |
|
|
IPM |
3 |
42,286,140 |
42,360,793 |
RGD:2302244 |
RGD |
| G |
Lep |
leptin |
|
Disease_progression |
ISS |
4 |
55,943,837 |
55,945,938 |
RGD:5128713 |
RGD |
| G |
Lep |
leptin |
|
|
IPM |
4 |
55,943,837 |
55,945,938 |
RGD:5128589 |
RGD |
| G |
Lrp6 |
low density lipoprotein receptor-related protein 6 |
|
|
ISS |
4 |
171,337,114 |
171,444,932 |
RGD:4110127 |
RGD |
| G |
Met |
met proto-oncogene |
|
|
IEP |
4 |
43,134,183 |
43,211,355 |
RGD:2317516 |
RGD |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
IEP |
20 |
13,191,986 |
13,192,851 |
RGD:1642000 |
RGD |
| G |
Mmp3 |
matrix metallopeptidase 3 |
|
|
IEP |
8 |
4,315,601 |
4,329,146 |
RGD:2325929 |
RGD |
| G |
Mt-cyb |
mitochondrially encoded cytochrome b |
|
|
IEP |
MT |
14,136 |
15,278 |
RGD:2298972 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:2325278 |
RGD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
|
IEP |
10 |
65,036,884 |
65,072,453 |
RGD:2325265 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IEP |
4 |
6,158,847 |
6,179,441 |
RGD:2292140 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IEP |
4 |
6,158,847 |
6,179,441 |
RGD:2292126 |
RGD |
| G |
Otc |
ornithine carbamoyltransferase |
|
|
IEP |
X |
24,609,141 |
24,685,341 |
RGD:4144080 |
RGD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
IPM |
18 |
57,014,475 |
57,053,581 |
RGD:2292206 |
RGD |
| G |
Pdxk |
pyridoxal (pyridoxine, vitamin B6) kinase |
|
|
IEP |
20 |
10,541,656 |
10,563,199 |
RGD:2303021 |
RGD |
| G |
Pgf |
placental growth factor |
|
|
ISS |
6 |
109,215,540 |
109,226,122 |
RGD:6483607 |
RGD |
| G |
Pgf |
placental growth factor |
|
Disease_progression |
IEP |
6 |
109,215,540 |
109,226,122 |
RGD:1643338 |
RGD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
|
IEP |
13 |
64,135,729 |
64,280,815 |
RGD:1642445 |
RGD |
| G |
Plat |
plasminogen activator, tissue |
|
|
IED |
16 |
73,711,323 |
73,736,328 |
RGD:6484134 |
RGD |
| G |
Plau |
plasminogen activator, urokinase |
|
|
IED |
15 |
3,680,072 |
3,686,232 |
RGD:6484134 |
RGD |
| G |
Plau |
plasminogen activator, urokinase |
|
Treatment |
IPM |
15 |
3,680,072 |
3,686,232 |
RGD:7241553 |
RGD |
| G |
Plau |
plasminogen activator, urokinase |
|
|
ISS |
15 |
3,680,072 |
3,686,232 |
RGD:2317516 |
RGD |
| G |
Plau |
plasminogen activator, urokinase |
|
|
IEP |
15 |
3,680,072 |
3,686,232 |
RGD:6484134 |
RGD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
|
IPM |
4 |
151,492,220 |
151,617,331 |
RGD:2301874 |
RGD |
| G |
Pros1 |
protein S (alpha) |
|
|
IEP |
|
|
|
RGD:2300011 |
RGD |
| G |
Ptk2 |
protein tyrosine kinase 2 |
|
|
IEP |
7 |
110,933,298 |
111,084,554 |
RGD:2292604 |
RGD |
| G |
Ramp2 |
receptor (G protein-coupled) activity modifying protein 2 |
|
|
IEP |
10 |
90,275,463 |
90,277,242 |
RGD:1625319 |
RGD |
| G |
Reln |
reelin |
|
|
IEP |
4 |
8,150,873 |
8,609,141 |
RGD:2317777 |
RGD |
| G |
Rhoa |
ras homolog family member A |
|
|
IEP |
|
|
|
RGD:1642803 |
RGD |
| G |
Rhoa |
ras homolog family member A |
|
|
IEP |
|
|
|
RGD:2298879 |
RGD |
| G |
Rxra |
retinoid X receptor alpha |
|
|
ISS |
3 |
6,605,782 |
6,689,224 |
RGD:1643114 |
RGD |
| G |
Selp |
selectin P |
|
|
IEP |
13 |
79,886,614 |
79,922,180 |
RGD:2312308 |
RGD |
| G |
Serpinc1 |
serpin peptidase inhibitor, clade C (antithrombin), member 1 |
|
Resistance |
IED |
13 |
76,548,456 |
76,562,724 |
RGD:1599330 |
RGD |
| G |
Skil |
SKI-like oncogene |
|
|
IEP |
2 |
116,669,375 |
116,691,472 |
RGD:2308901 |
RGD |
| G |
Smad1 |
SMAD family member 1 |
|
|
IEP |
19 |
30,348,886 |
30,409,345 |
RGD:1643229 |
RGD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
|
IPM |
10 |
40,809,730 |
40,831,481 |
RGD:2300030 |
RGD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
|
IEP |
10 |
40,809,730 |
40,831,481 |
RGD:2300071 |
RGD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
|
IED |
|
|
|
RGD:1581332 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
IEP |
1 |
80,894,705 |
80,911,020 |
RGD:1601595 |
RGD |
| G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
|
|
IPM |
5 |
63,976,868 |
64,034,058 |
RGD:2302027 |
RGD |
| G |
Tgfbr1 |
transforming growth factor, beta receptor 1 |
|
|
IEP |
5 |
63,976,868 |
64,034,058 |
RGD:1601595 |
RGD |
| G |
Tgfbr2 |
transforming growth factor, beta receptor II |
|
|
IED |
8 |
120,593,595 |
120,680,453 |
RGD:1579923 |
RGD |
| G |
Th |
tyrosine hydroxylase |
|
|
IEP |
1 |
203,164,253 |
203,171,506 |
RGD:5129683 |
RGD |
| G |
Thbd |
thrombomodulin |
|
|
IEP |
3 |
137,158,955 |
137,162,607 |
RGD:5685038 |
RGD |
| G |
Thpo |
thrombopoietin |
|
|
IEP |
11 |
82,412,552 |
82,417,807 |
RGD:1580082 |
RGD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
|
IEP |
X |
12,542,496 |
12,547,094 |
RGD:2290364 |
RGD |
| G |
Tlr2 |
toll-like receptor 2 |
|
Treatment |
IED |
2 |
175,607,990 |
175,613,992 |
RGD:7241092 |
RGD |
| G |
Tlr4 |
toll-like receptor 4 |
|
Treatment |
IED |
5 |
83,564,100 |
83,577,735 |
RGD:7241092 |
RGD |
Term paths to the root
|